MTOR and nonpapillary renal cell carcinoma: Further TIMER and TISIDB databases analysis revealed mTOR could regulate numerous immune cells (including TIICs and TILs) and immunoinhibitors in >500 ccRCC patients (P < 0.001, respectively), and HE staining revealed the close relationship between p-mTOR expression and the infiltration of immune cells.